Nifty

:

23123.00

Sensex

:

73524.26

-243.70 (-1.04%)
-719.08 (-0.97%)

Login

Nifty
Sensex

:
:

23123.00
73524.26

-243.70 (-1.04%)
-719.08 (-0.97%)

SMS Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

Rating :

67/99

BSE: 532815 | NSE: SMSPHARMA

Watchlist

NSE BSE

368.80

08-Jun-2026

Open
High
Low
Previous Close

363.25
375.95
363.25
369.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

183381
68071996.55
447.8
207.7

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,454.36
33.87
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,773.33
0.11%
4.40

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.50
6.81
14.46

EBITDA CAGR (%)

10 Years
5 Years
3 Years

4.53
2.79
20.58

PAT CAGR (%)

10 Years
5 Years
3 Years

4.93
2.03
158.99

P:E (Median)

8 Years
5 Years
3 Years

22.71
30.31
35.38

P:BV (Average)

8 Years
5 Years
3 Years

2.51
2.90
3.48

EV:EBITDA (Average)

8 Years
5 Years
3 Years

13.15
16.11
17.76

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 237.95 248.20 -4.13% 210.45 173.35 21.40% 242.43 196.75 23.22% 196.05 164.45 19.22%
Expenses 198.07 206.85 -4.24% 166.65 140.05 18.99% 194.05 164.89 17.68% 157.19 130.99 20.00%
EBITDA 39.88 41.35 -3.56% 43.79 33.30 31.50% 48.38 31.86 51.85% 38.86 33.47 16.10%
EBIDTM 16.76% 16.66% 20.81% 19.21% 19.96% 16.19% 19.82% 20.35%
Other Income 2.57 1.42 80.99% 3.75 2.13 76.06% 1.43 1.31 9.16% 0.59 1.37 -56.93%
Interest 5.28 5.06 4.35% 6.22 4.20 48.10% 5.74 4.61 24.51% 5.84 4.67 25.05%
Depreciation 10.13 8.64 17.25% 10.02 8.70 15.17% 10.02 8.62 16.24% 9.75 8.38 16.35%
PBT 27.04 29.06 -6.95% 31.31 22.53 38.97% 34.06 19.94 70.81% 23.86 21.78 9.55%
Tax 6.13 8.44 -27.37% 7.97 5.36 48.69% 8.91 5.68 56.87% 5.65 5.46 3.48%
PAT 20.92 20.62 1.45% 23.34 17.17 35.93% 25.14 14.26 76.30% 18.21 16.33 11.51%
PATM 8.79% 8.31% 11.09% 9.91% 10.37% 7.25% 9.29% 9.93%
EPS 2.23 2.20 1.36% 2.49 1.83 36.07% 2.68 1.52 76.32% 1.94 1.74 11.49%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 237.95 248.20 -4.13% 210.45 173.35 21.40% 242.43 196.75 23.22% 196.05 164.45 19.22%
Expenses 198.05 207.39 -4.50% 166.80 140.14 19.02% 194.06 165.28 17.41% 156.68 130.94 19.66%
EBITDA 39.90 40.81 -2.23% 43.64 33.21 31.41% 48.37 31.47 53.70% 39.37 33.51 17.49%
EBIDTM 16.77% 16.44% 20.74% 19.16% 19.95% 15.99% 20.08% 20.38%
Other Income 2.57 1.42 80.99% 3.75 2.13 76.06% 1.43 1.31 9.16% 0.59 1.37 -56.93%
Interest 5.28 5.06 4.35% 6.22 4.20 48.10% 5.74 4.61 24.51% 5.84 4.67 25.05%
Depreciation 10.13 8.64 17.25% 10.02 8.70 15.17% 10.02 8.62 16.24% 9.75 8.38 16.35%
PBT 27.07 28.52 -5.08% 31.16 22.44 38.86% 34.04 19.54 74.21% 24.37 21.83 11.64%
Tax 6.10 8.44 -27.73% 7.97 5.36 48.69% 8.91 5.68 56.87% 5.65 5.46 3.48%
PAT 20.96 20.08 4.38% 23.19 17.08 35.77% 25.13 13.86 81.31% 18.71 16.37 14.29%
PATM 8.81% 8.09% 11.02% 9.85% 10.37% 7.05% 9.55% 9.96%
EPS 3.49 2.29 52.40% 2.51 2.15 16.74% 2.70 1.67 61.68% 2.31 1.95 18.46%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 886.88 782.75 709.26 522.05 519.87 563.18 411.95 464.91 464.93 445.49 611.53 Net Sales Growth 13.30% 10.36% 35.86% 0.42% -7.69% 36.71% -11.39% 0.00% 4.36% -27.15% Cost Of Goods Sold 498.48 436.09 424.04 335.60 275.30 340.00 246.36 292.71 289.90 295.85 385.15 Gross Profit 388.40 346.66 285.22 186.44 244.58 223.18 165.59 172.20 175.03 149.64 226.38 GP Margin 43.79% 44.29% 40.21% 35.71% 47.05% 39.63% 40.20% 37.04% 37.65% 33.59% 37.02% Total Expenditure 715.96 642.77 592.28 467.32 405.10 442.04 331.92 374.77 371.59 370.35 522.32 Power & Fuel Cost - 56.76 47.12 35.97 32.58 23.31 18.99 21.75 22.57 18.23 33.81 % Of Sales - 7.25% 6.64% 6.89% 6.27% 4.14% 4.61% 4.68% 4.85% 4.09% 5.53% Employee Cost - 69.72 56.78 50.08 51.02 41.17 39.35 35.59 32.80 26.92 38.11 % Of Sales - 8.91% 8.01% 9.59% 9.81% 7.31% 9.55% 7.66% 7.05% 6.04% 6.23% Manufacturing Exp. - 42.85 37.87 28.08 25.80 16.28 14.89 13.29 12.14 10.35 37.94 % Of Sales - 5.47% 5.34% 5.38% 4.96% 2.89% 3.61% 2.86% 2.61% 2.32% 6.20% General & Admin Exp. - 22.45 20.68 12.48 15.32 14.93 8.05 8.69 8.45 9.00 10.51 % Of Sales - 2.87% 2.92% 2.39% 2.95% 2.65% 1.95% 1.87% 1.82% 2.02% 1.72% Selling & Distn. Exp. - 13.75 4.73 3.82 3.42 5.09 3.70 2.25 4.81 9.67 15.99 % Of Sales - 1.76% 0.67% 0.73% 0.66% 0.90% 0.90% 0.48% 1.03% 2.17% 2.61% Miscellaneous Exp. - 1.17 1.07 1.27 1.67 1.25 0.58 0.49 0.91 0.33 15.99 % Of Sales - 0.15% 0.15% 0.24% 0.32% 0.22% 0.14% 0.11% 0.20% 0.07% 0.13% EBITDA 170.91 139.98 116.98 54.73 114.77 121.14 80.03 90.14 93.34 75.14 89.21 EBITDA Margin 19.27% 17.88% 16.49% 10.48% 22.08% 21.51% 19.43% 19.39% 20.08% 16.87% 14.59% Other Income 8.34 6.22 4.46 4.91 5.20 3.45 5.11 3.40 2.39 1.45 3.61 Interest 23.08 18.54 23.60 21.97 19.16 11.19 12.32 11.92 15.48 15.82 17.11 Depreciation 39.92 34.34 31.52 32.13 32.15 22.28 22.07 19.27 19.90 19.18 19.43 PBT 116.27 93.32 66.33 5.55 68.65 91.12 50.76 62.35 60.35 41.58 56.27 Tax 28.66 24.94 16.91 1.47 0.62 30.16 18.07 20.90 19.89 5.97 14.63 Tax Rate 24.65% 26.73% 25.49% 26.49% 0.90% 33.10% 35.60% 33.52% 32.96% 14.36% 26.00% PAT 87.61 68.38 49.42 4.08 68.04 60.96 32.69 41.45 40.45 35.61 41.64 PAT before Minority Interest 87.61 68.38 49.42 4.08 68.04 60.96 32.69 41.45 40.45 35.61 41.64 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.88% 8.74% 6.97% 0.78% 13.09% 10.82% 7.94% 8.92% 8.70% 7.99% 6.81% PAT Growth 28.12% 38.37% 1,111.27% -94.00% 11.61% 86.48% -21.13% 2.47% 13.59% -14.48% EPS 9.35 7.30 5.27 0.44 7.26 6.51 3.49 4.42 4.32 3.80 4.44

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 886.88 782.75 709.26 522.05 519.87 563.18 411.95 464.91 464.93 445.49 611.53 Net Sales Growth 13.30% 10.36% 35.86% 0.42% -7.69% 36.71% -11.39% 0.00% 4.36% -27.15% Cost Of Goods Sold 497.79 437.06 424.26 335.80 275.45 340.00 246.36 292.71 289.90 295.85 385.15 Gross Profit 389.09 345.69 285.00 186.24 244.43 223.18 165.59 172.20 175.03 149.64 226.38 GP Margin 43.87% 44.16% 40.18% 35.67% 47.02% 39.63% 40.20% 37.04% 37.65% 33.59% 37.02% Total Expenditure 715.59 643.76 592.50 467.52 405.26 442.04 331.92 374.77 371.59 370.35 522.32 Power & Fuel Cost - 56.76 47.12 35.97 32.58 23.31 18.99 21.75 22.57 18.23 33.81 % Of Sales - 7.25% 6.64% 6.89% 6.27% 4.14% 4.61% 4.68% 4.85% 4.09% 5.53% Employee Cost - 69.72 56.78 50.08 51.02 41.17 39.35 35.59 32.80 26.92 38.11 % Of Sales - 8.91% 8.01% 9.59% 9.81% 7.31% 9.55% 7.66% 7.05% 6.04% 6.23% Manufacturing Exp. - 42.85 37.87 28.08 25.80 16.28 14.89 13.29 12.14 10.35 37.94 % Of Sales - 5.47% 5.34% 5.38% 4.96% 2.89% 3.61% 2.86% 2.61% 2.32% 6.20% General & Admin Exp. - 22.46 20.68 12.48 15.32 14.93 8.05 8.69 8.45 9.00 10.51 % Of Sales - 2.87% 2.92% 2.39% 2.95% 2.65% 1.95% 1.87% 1.82% 2.02% 1.72% Selling & Distn. Exp. - 13.75 4.73 3.82 3.42 5.09 3.70 2.25 4.81 9.67 15.99 % Of Sales - 1.76% 0.67% 0.73% 0.66% 0.90% 0.90% 0.48% 1.03% 2.17% 2.61% Miscellaneous Exp. - 1.17 1.07 1.27 1.67 1.25 0.58 0.49 0.91 0.33 15.99 % Of Sales - 0.15% 0.15% 0.24% 0.32% 0.22% 0.14% 0.11% 0.20% 0.07% 0.13% EBITDA 171.28 138.99 116.76 54.53 114.61 121.14 80.03 90.14 93.34 75.14 89.21 EBITDA Margin 19.31% 17.76% 16.46% 10.45% 22.05% 21.51% 19.43% 19.39% 20.08% 16.87% 14.59% Other Income 8.34 6.22 4.46 4.91 5.20 3.45 5.11 3.40 2.39 1.45 3.61 Interest 23.08 18.54 23.60 21.97 19.16 11.19 12.32 11.92 15.48 15.82 17.11 Depreciation 39.92 34.34 31.52 32.13 32.15 22.28 22.07 19.27 19.90 19.18 19.43 PBT 116.64 92.34 66.11 5.35 68.50 91.12 50.76 62.35 60.35 41.58 56.27 Tax 28.63 24.94 16.91 1.47 0.62 30.16 18.07 20.90 19.89 5.97 14.63 Tax Rate 24.55% 27.01% 25.58% 27.48% 0.91% 33.10% 35.60% 33.52% 32.96% 14.36% 26.00% PAT 87.99 67.40 49.20 3.88 67.88 60.96 32.69 41.45 40.45 35.61 41.64 PAT before Minority Interest 87.99 67.40 49.20 3.88 67.88 60.96 32.69 41.45 40.45 35.61 41.64 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.92% 8.61% 6.94% 0.74% 13.06% 10.82% 7.94% 8.92% 8.70% 7.99% 6.81% PAT Growth 30.57% 36.99% 1,168.04% -94.28% 11.35% 86.48% -21.13% 2.47% 13.59% -14.48% EPS 9.39 7.19 5.25 0.41 7.24 6.51 3.49 4.42 4.32 3.80 4.44

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 673.07 570.49 495.10 493.76 428.22 367.42 339.92 301.11 262.63 294.36 Share Capital 8.87 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 Total Reserves 648.33 533.45 486.63 485.30 419.76 358.96 331.46 292.64 254.17 285.90 Non-Current Liabilities 188.67 166.05 164.17 192.73 206.26 114.47 94.35 96.58 91.41 161.56 Secured Loans 138.16 120.89 119.93 148.30 146.21 67.02 61.01 70.20 73.02 109.58 Unsecured Loans 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 3.64 Long Term Provisions 1.21 1.16 1.40 1.57 1.84 1.73 1.52 2.18 1.35 3.43 Current Liabilities 344.50 346.72 254.97 211.48 211.43 154.21 156.05 134.29 156.00 200.43 Trade Payables 113.91 151.32 107.43 72.86 65.44 44.49 47.70 39.27 66.75 84.40 Other Current Liabilities 84.54 65.37 52.65 54.69 58.31 38.84 23.32 22.91 19.95 40.37 Short Term Borrowings 124.80 114.00 93.79 67.91 70.86 61.16 70.81 58.40 59.76 72.75 Short Term Provisions 21.24 16.03 1.10 16.02 16.82 9.72 14.22 13.71 9.54 2.90 Total Liabilities 1,206.24 1,083.26 914.24 897.97 845.91 636.10 590.32 531.98 510.04 656.35 Net Block 532.98 437.26 412.02 437.99 457.36 280.49 281.26 279.26 290.45 370.35 Gross Block 760.33 630.61 575.55 569.62 558.80 360.77 339.57 318.34 309.63 433.08 Accumulated Depreciation 227.35 193.35 163.53 131.63 101.44 80.29 58.31 39.08 19.18 62.73 Non Current Assets 631.64 534.36 503.54 505.92 520.58 408.32 369.23 350.66 343.68 408.79 Capital Work in Progress 34.67 30.27 33.19 11.00 6.74 42.12 18.30 8.20 7.76 12.80 Non Current Investment 45.11 45.10 45.10 45.00 45.00 45.00 45.00 45.00 36.98 21.27 Long Term Loans & Adv. 15.94 19.04 10.70 9.32 9.10 38.47 22.55 16.19 6.58 4.37 Other Non Current Assets 2.95 2.69 2.54 2.61 2.38 2.25 2.13 2.01 1.90 0.00 Current Assets 574.60 548.89 410.70 392.05 325.33 227.78 221.09 181.32 166.36 247.55 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 284.73 233.70 223.50 251.10 137.79 129.20 136.40 107.48 92.52 112.68 Sundry Debtors 203.23 236.23 148.35 48.52 105.68 48.77 26.02 24.15 21.32 61.09 Cash & Bank 41.58 36.20 7.47 46.66 40.51 9.65 14.88 12.71 12.37 15.08 Other Current Assets 45.05 6.77 6.00 6.39 41.35 40.15 43.79 36.98 40.15 58.70 Short Term Loans & Adv. 36.61 35.99 25.39 39.39 22.17 36.33 17.06 14.89 11.67 23.49 Net Current Assets 230.10 202.18 155.74 180.57 113.90 73.57 65.04 47.03 10.36 47.13 Total Assets 1,206.24 1,083.25 914.24 897.97 845.91 636.10 590.32 531.98 510.04 656.34

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 639.64 536.33 460.53 470.29 410.53 348.24 321.92 284.49 254.74 293.60 Share Capital 8.87 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 Total Reserves 614.90 499.29 452.06 461.82 402.06 339.77 313.45 276.02 246.28 285.14 Non-Current Liabilities 188.67 166.05 164.17 192.73 206.26 114.47 94.35 96.58 91.41 161.56 Secured Loans 138.16 120.89 119.93 148.30 146.21 67.02 61.01 70.20 73.02 109.58 Unsecured Loans 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 3.64 Long Term Provisions 1.21 1.16 1.40 1.57 1.84 1.73 1.52 2.18 1.35 3.43 Current Liabilities 344.50 346.72 254.97 211.48 211.43 154.21 156.05 134.29 156.00 200.43 Trade Payables 113.92 151.32 107.43 72.86 65.44 44.49 47.70 39.27 66.75 84.40 Other Current Liabilities 84.54 65.37 52.65 54.69 58.31 38.84 23.32 22.91 19.95 40.37 Short Term Borrowings 124.80 114.00 93.79 67.91 70.86 61.16 70.81 58.40 59.76 72.75 Short Term Provisions 21.24 16.03 1.10 16.02 16.82 9.72 14.22 13.71 9.54 2.90 Total Liabilities 1,172.81 1,049.10 879.67 874.50 828.22 616.92 572.32 515.36 502.15 655.59 Net Block 532.98 437.26 412.02 437.99 457.36 280.49 281.26 279.26 290.45 370.35 Gross Block 760.33 630.61 575.55 569.62 558.80 360.77 339.57 318.34 309.63 500.81 Accumulated Depreciation 227.35 193.35 163.53 131.63 101.44 80.29 58.31 39.08 19.18 130.46 Non Current Assets 598.21 500.20 468.96 482.45 502.88 389.13 351.22 334.04 335.80 408.04 Capital Work in Progress 34.67 30.27 33.19 11.00 6.74 42.12 18.30 8.20 7.76 12.80 Non Current Investment 11.68 10.94 10.52 21.53 27.30 25.81 26.99 28.38 29.10 20.51 Long Term Loans & Adv. 15.94 19.04 10.70 9.32 9.10 38.47 22.55 16.19 6.58 4.37 Other Non Current Assets 2.95 2.69 2.54 2.61 2.38 2.25 2.13 2.01 1.90 0.00 Current Assets 574.60 548.89 410.70 392.05 325.33 227.78 221.09 181.32 166.36 247.55 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 284.73 233.70 223.50 251.10 137.79 129.20 136.40 107.48 92.52 112.68 Sundry Debtors 203.23 236.23 148.35 48.52 105.68 48.77 26.02 24.15 21.32 61.09 Cash & Bank 41.59 36.20 7.47 46.66 40.51 9.65 14.88 12.71 12.37 15.08 Other Current Assets 45.05 6.77 6.00 6.39 41.35 40.15 43.79 36.98 40.15 58.70 Short Term Loans & Adv. 36.61 35.99 25.39 39.39 22.17 36.33 17.06 14.89 11.67 23.49 Net Current Assets 230.10 202.18 155.74 180.57 113.90 73.57 65.04 47.03 10.36 47.13 Total Assets 1,172.81 1,049.09 879.66 874.50 828.21 616.91 572.31 515.36 502.16 655.59

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 81.71 50.12 22.45 45.06 90.45 39.71 49.76 31.81 73.47 61.22 PBT 93.32 66.33 5.55 68.65 91.12 50.76 62.35 60.35 41.58 56.27 Adjustment 51.31 53.74 52.79 49.70 27.76 28.66 26.81 31.08 31.58 28.14 Changes in Working Capital -43.08 -54.55 -31.29 -58.38 -12.38 -27.60 -26.02 -48.48 9.40 -1.17 Cash after chg. in Working capital 101.55 65.52 27.05 59.98 106.50 51.82 63.14 42.95 82.56 83.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -19.83 -15.40 -4.60 -14.92 -16.05 -12.10 -13.38 -11.14 -9.09 -22.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -123.44 -52.07 -29.76 -27.15 -151.59 -42.56 -34.67 -16.58 -38.96 -96.72 Net Fixed Assets -134.12 -52.14 -28.12 -15.08 -162.65 -45.02 -31.33 -9.15 128.49 -28.01 Net Investments -0.01 0.00 -0.10 0.00 0.00 0.00 0.00 -8.02 -15.71 -8.04 Others 10.69 0.07 -1.54 -12.07 11.06 2.46 -3.34 0.59 -151.74 -60.67 Cash from Financing Activity 47.08 30.68 -31.97 -11.75 92.02 -2.40 -12.92 -14.89 -33.19 44.34 Net Cash Inflow / Outflow 5.35 28.73 -39.27 6.16 30.88 -5.25 2.17 0.35 1.32 8.84 Opening Cash & Equivalents 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25 2.41 Closing Cash & Equivalent 41.39 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 81.71 50.12 22.45 45.06 90.45 39.71 49.76 31.81 73.47 61.22 PBT 92.34 66.11 5.35 68.50 91.12 50.76 62.35 60.35 41.58 56.27 Adjustment 52.28 53.97 52.99 49.86 27.76 28.66 26.81 31.08 31.58 28.14 Changes in Working Capital -43.08 -54.55 -31.29 -58.38 -12.38 -27.60 -26.02 -48.48 9.40 -1.17 Cash after chg. in Working capital 101.54 65.52 27.05 59.98 106.50 51.82 63.14 42.95 82.56 83.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -19.83 -15.40 -4.60 -14.92 -16.05 -12.10 -13.38 -11.14 -9.09 -22.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -123.43 -52.07 -29.76 -27.15 -151.59 -42.56 -34.67 -16.58 -38.96 -96.72 Net Fixed Assets -134.12 -52.14 -28.12 -15.08 -162.65 -45.02 -31.33 -9.15 128.49 Net Investments -0.01 0.00 -0.10 0.00 0.00 0.00 0.00 -8.02 -15.71 Others 10.70 0.07 -1.54 -12.07 11.06 2.46 -3.34 0.59 -151.74 Cash from Financing Activity 47.08 30.68 -31.97 -11.75 92.02 -2.40 -12.92 -14.89 -33.19 44.34 Net Cash Inflow / Outflow 5.36 28.73 -39.27 6.16 30.88 -5.25 2.17 0.35 1.32 8.84 Opening Cash & Equivalents 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25 2.41 Closing Cash & Equivalent 41.40 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 74.13 64.02 58.49 58.33 50.59 43.40 40.16 35.57 31.02 34.77 ROA 5.97% 4.95% 0.45% 7.80% 8.23% 5.33% 7.39% 7.76% 6.11% 6.96% ROE 11.41% 9.53% 0.83% 14.76% 15.32% 9.24% 12.93% 14.35% 12.79% 15.17% ROCE 12.20% 11.25% 3.67% 12.26% 17.07% 12.57% 15.96% 17.66% 12.61% 15.95% Fixed Asset Turnover 1.22 1.27 0.97 0.98 1.32 1.29 1.53 1.59 1.22 1.53 Receivable days 94.73 91.77 65.01 50.80 46.40 30.27 18.23 16.66 33.12 34.86 Inventory Days 111.76 109.10 156.71 128.12 80.21 107.49 88.61 73.28 82.47 57.59 Payable days 111.00 111.36 98.04 91.68 59.01 46.62 40.24 46.81 71.90 49.65 Cash Conversion Cycle 95.49 89.51 123.68 87.24 67.61 91.14 66.60 43.12 43.69 42.80 Total Debt/Equity 0.47 0.52 0.51 0.53 0.59 0.41 0.42 0.49 0.57 0.69 Interest Cover 6.03 3.81 1.25 4.58 9.14 5.12 6.23 4.90 3.63 4.29

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 70.36 59.98 54.40 55.56 48.50 41.14 38.03 33.61 30.09 34.68 ROA 6.07% 5.10% 0.44% 7.97% 8.44% 5.50% 7.62% 7.95% 6.15% 8.46% ROE 11.91% 10.16% 0.83% 15.41% 16.07% 9.76% 13.67% 15.00% 12.99% 17.57% ROCE 12.55% 11.73% 3.79% 12.60% 17.62% 13.06% 16.57% 18.17% 12.73% 19.54% Fixed Asset Turnover 1.22 1.27 0.97 0.98 1.32 1.29 1.53 1.59 1.12 2.11 Receivable days 94.73 91.77 65.01 50.80 46.40 30.27 18.23 16.66 33.12 35.09 Inventory Days 111.76 109.10 156.71 128.12 80.21 107.49 88.61 73.28 82.47 47.02 Payable days 110.75 111.30 97.98 91.63 59.01 46.62 40.24 46.81 71.90 36.96 Cash Conversion Cycle 95.74 89.57 123.74 87.30 67.61 91.14 66.60 43.12 43.69 45.14 Total Debt/Equity 0.50 0.55 0.55 0.55 0.61 0.44 0.45 0.51 0.59 0.70 Interest Cover 5.98 3.80 1.24 4.57 9.14 5.12 6.23 4.90 3.63 4.29

Top Investors:

quant mutual fund - quant small cap fund

venkata subbaraju penmatsa (huf)

sudeepthi gopineedi

venkata praveen talluri

investor education and protection fund (iepf)

Annual Reports:

News Update:

SMS Pharmaceuticals - Quarterly Results
23rd May 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback